Two New Jersey fertility clinics made Newsweek’s 2026 rankings, with RMA New Jersey placing in the top 10, as experts highlight rising demand and innovation in reproductive healthcare nationwide.
NEWSDESK – NJNEWSLINE
Two New Jersey fertility centers have been recognized in Newsweek’s “America’s Best Fertility Clinics 2026” rankings, with one securing a coveted top-10 position.
The list, released April 22 in partnership with data analytics firm Statista, evaluated 140 clinics across 32 states and Washington, D.C., based on clinical quality, patient satisfaction, reputation, and accreditations.
Leading the state’s representation is RMA New Jersey in Basking Ridge, which ranked No. 8 nationwide. Another entrant, Fertility Institute of New Jersey & New York in Oradell, placed No. 135.
The number of New Jersey clinics featured dropped from four in 2025 to two this year, reflecting increased competition and stricter evaluation criteria.
According to Newsweek, top-ranked clinics “combine clinical excellence with innovation,” as fertility care continues to evolve with advancements in artificial intelligence and genomics.
“In 2026, fertility care is a high-tech frontier of AI and genomics,” said Alexis Kayser, healthcare editor at Newsweek, noting that more than 100,000 babies are born annually in the U.S. through in vitro fertilization (IVF).
The rankings drew on data from the Centers for Disease Control and Prevention, along with surveys and performance indicators, to assess outcomes and patient experiences.
IVI RMA North America, which includes RMA New Jersey, said 10 of its clinics nationwide made the list. The Basking Ridge facility serves as the company’s headquarters.
CEO Lynn Mason said the recognition reflects the dedication of clinical teams focused on achieving successful outcomes for patients seeking fertility treatments.
The company has also expanded access to care through partnerships with major retailers and digital health platforms, aiming to make fertility services more affordable and widely available.
The latest rankings underscore the growing normalization of fertility treatments in the U.S., as demand rises and technology continues to reshape reproductive healthcare.
